OTCMKTS:RPBC Redpoint Bio Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Redpoint Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0001 0.00 (0.00 %) (As of 07/23/2019) Add Compare Share Today's Range$0.00Now: $0.00▼$0.0050-Day Range N/A52-Week Range$0.00Now: $0.00▼$0.00Volume200,000 shsAverage Volume101,150 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Redpoint Bio. Previous Next 2.5 Community Rank Outperform VotesRedpoint Bio has received 64 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRedpoint Bio has received 64 “underperform” votes. (Add your “underperform” vote.)Community SentimentRedpoint Bio has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Redpoint Bio and other stocks. Vote “Outperform” if you believe RPBC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RPBC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRedpoint Bio does not currently pay a dividend.Dividend GrowthRedpoint Bio does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Redpoint Bio insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 11.51% of the stock of Redpoint Bio is held by insiders. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:RPBC Previous Symbol CUSIP757736103 CIK1328003 Webwww.redpointbio.com Phone215-456-2312Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $0.0001 0.00 (0.00 %) (As of 07/23/2019) 30 days | 90 days | 365 days | Advanced Chart Receive RPBC News and Ratings via Email Sign-up to receive the latest news and ratings for RPBC and its competitors with MarketBeat's FREE daily newsletter. Redpoint Bio (OTCMKTS:RPBC) Frequently Asked Questions How has Redpoint Bio's stock price been impacted by Coronavirus? Redpoint Bio's stock was trading at $0.0001 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RPBC stock has increased by 0.0% and is now trading at $0.0001. View which stocks have been most impacted by COVID-19. Who are some of Redpoint Bio's key competitors? Some companies that are related to Redpoint Bio include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), PPD (PPD), Charles River Laboratories Intl. (CRL), Icon (ICLR), Exelixis (EXEL), PRA Health Sciences (PRAH), Syneos Health (SYNH), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Precigen (PGEN), STARPHARMA HOLD/S (SPHRY) and Anavex Life Sciences (AVXL). View all competitors. What other stocks do shareholders of Redpoint Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Redpoint Bio investors own include Twitter (TWTR), TowneBank (TOWN), Hershey (HSY), Ferro (FOE) and BMC Stock (BMCH). Who are Redpoint Bio's key executives? Redpoint Bio's management team includes the following people: Dr. R. Kyle Palmer Ph.D., Sr. Director of Discovery Research What is Redpoint Bio's stock symbol? Redpoint Bio trades on the OTCMKTS under the ticker symbol "RPBC." How do I buy shares of Redpoint Bio? Shares of RPBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Redpoint Bio's stock price today? One share of RPBC stock can currently be purchased for approximately $0.00. What is Redpoint Bio's official website? The official website for Redpoint Bio is www.redpointbio.com. How can I contact Redpoint Bio? Redpoint Bio's mailing address is 7 GRAPHICS DRIVE, EWING NJ, 08628. The company can be reached via phone at 215-456-2312. This page was last updated on 9/24/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
